RE: 40p open tomm28 Nov 2019 13:00
Results released in July confirmed Lupuzor’s “outstanding and robust safety profile”, with no serious adverse events reported.
On top of that, ImmuPharma was also able to show a third of the patients taking the drug were in remission at the end of the assessment.
Get in before the weekend guys, just watch the massive buys, follow the money.